Frequency of Osteoporosis in Patients Presenting with Chronic Liver Disease at Tertiary Care Hospital Karachi
Osteoporosis in Patients Presenting with Chronic Liver Disease
DOI:
https://doi.org/10.54393/pjhs.v6i5.3204Keywords:
Osteoporosis, Chronic Liver Disease, Bone Mineral Density, Dual-Energy X-ray AbsorptiometryAbstract
Osteoporosis is a disease of low bone mass and micro-architectural deterioration of bone tissue, resulting in bone fragility and an increased risk of fractures. Because osteoporosis suddenly manifests with fractures at multiple skeletal sites, most often at the spine, hip, or wrist, it is termed "silent disease". This becomes even important in CLD patients. Objective: To determine the frequency of osteoporosis in patients presenting with chronic liver disease (CLD) at Al Tibri Medical College and Hospital, Karachi. Methods: A Total of 120 CLD patients of either gender were included. Data like age, gender, residence, and duration of CLD were recorded and followed by a study of bone mineral density (BMD) in the distal forearm of the non-dominant hand using dual-energy X-ray absorptiometry (DEXA). If BMD <–2.5 SD, then osteoporosis was positive. SPSS version 23.0 was used for analysis. Descriptive statistics were calculated. Effect modification was controlled through Chi-square. p-value<0.05 was considered significant. Results: The mean age was 39.49 ± 8.12 years. Mean CLD duration was 5.93 ± 2.29 years. Male were 68.3%. A total of 31.7% of patients with CLD had a BMD score <–2.5 SD and were observed as osteoporosis. The frequency of osteoporosis decreased with increasing age, but not statistically significant. Numerically, male was more affected than female, however, with an insignificant association. The duration of CLD was an effect modifier insignificantly. Conclusion: Almost every third patient of CLD has osteoporosis. The current study recommends screening of all such patients.
References
Jadzic J and Djonic D. Bone Loss in Chronic Liver Diseases: Could Healthy Liver Be A Requirement for Good Bone Health? World Journal of Gastroenterology. 2023 Feb; 29(5): 825. doi: 10.3748/wjg.v29.i5.825.
Loosen SH, Roderburg C, Demir M, Qvartskhava N, Keitel V, Kostev K et al. Non-alcoholic Fatty Liver Disease (NAFLD) Is Associated with an Increased Incidence of Osteoporosis and Bone Fractures. Zeitschrift Für Gastroenterologie. 2022 Aug; 60(08): 1221-7. doi: 10.1055/a-1482-9236.
Jeong HM and Kim DJ. Bone Diseases in Patients with Chronic Liver Disease. International Journal of Molecular Sciences. 2019 Aug; 20(17): 4270. doi: 10.3390/ijms20174270.
Muhsen IN, AlFreihi O, Abaalkhail F, AlKhenizan A, Khan M, Eldali A et al. Bone Mineral Density Loss in Patients with Cirrhosis. Saudi Journal of Gastroenterology. 2018 Nov; 24(6): 342-7. doi: 10.4103/sjg.SJG_74_18.
Guañabens N and Parés A. Osteoporosis in Chronic Liver Disease. Liver International. 2018 May; 38(5): 776-85. doi: 10.1111/liv.13730.
Hidalgo DF, Boonpheng B, Sikandar S, Nasr L, Hidalgo J. Chronic Liver Disease and the Risk of Osteoporotic Fractures: A Meta-Analysis. Cureus. 2020 Sep; 12(9). doi: 10.7759/cureus.10483.
Hsu CS and Kao JH. Sarcopenia and Chronic Liver Diseases. Expert Review of Gastroenterology and Hepatology. 2018 Dec; 12(12): 1229-44. doi: 10.1080/17474124.2018.1534586.
Yang YJ and Kim DJ. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. International Journal of Molecular Sciences. 2021 Mar; 22(5): 2604. doi: 10.3390/ijms22052604.
Danford CJ, Trivedi HD, Bonder A. Bone Health in Patients with Liver Diseases. Journal of Clinical Densitometry. 2020 Apr; 23(2): 212-22. doi: 10.1016/j.jocd.2019.01.004.
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MD, López-Ruiz E. Current Status of the Diagnosis and Management of Osteoporosis. International Journal of Molecular Sciences. 2022 Aug; 23(16): 9465. doi: 10.3390/ijms23169465.
Ionele CM, Turcu-Stiolica A, Subtirelu MS, Ungureanu BS, Sas TN, Rogoveanu I. Osteoporosis Assessment Among Adults with Liver Cirrhosis. Journal of Clinical Medicine. 2022 Dec; 12(1): 153. doi: 10.3390/jcm12010153.
Asrani SK, Kouznetsova M, Ogola G, Taylor T, Masica A, Pope B et al. Increasing Health Care Burden of Chronic Liver Disease Compared with Other Chronic Diseases, 2004–2013. Gastroenterology. 2018 Sep; 155(3): 719-29. doi: 10.1053/j.gastro.2018.05.032.
Pan B, Cai J, Zhao P, Liu J, Fu S, Jing G et al. Relationship Between Prevalence and Risk of Osteoporosis or Osteoporotic Fracture with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Osteoporosis International. 2022 Nov; 33(11): 2275-86. doi: 10.1007/s00198-022-06459-y.
Saeki C, Saito M, Tsubota A. Association of Chronic Liver Disease with Bone Diseases and Muscle Weakness. Journal of Bone and Mineral Metabolism. 2024 Jul; 42(4): 399-412. doi: 10.1007/s00774-023-01488-x.
Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: Pathophysiology and Therapeutic Options. EXCLI Journal. 2020 Jul; 19: 1017.
Saeki C and Tsubota A. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life. 2021 Aug; 11(9): 899. doi: 10.3390/life11090899.
Mantovani A, Dauriz M, Gatti D, Viapiana O, Zoppini G, Lippi G et al. Systematic Review with Meta‐Analysis: Non‐Alcoholic Fatty Liver Disease Is Associated with A History of Osteoporotic Fractures but Not with Low Bone Mineral Density. Alimentary Pharmacology and Therapeutics. 2019 Feb; 49(4): 375-88. doi: 10.1111/apt.15087.
Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polyzos SA. Nonalcoholic Fatty Liver Disease and Osteoporosis: A Potential Association with Therapeutic Implications. Diabetes, Obesity and Metabolism. 2022 Sep; 24(9): 1702-20. doi: 10.1111/dom.14774.
Roy K. Osteoporosis: A Silent Life Threatening Disease: Osteoporosis: A Silent Life Threatening Disease. Indian Journal of Physiology and Allied Sciences. 2021; 73(1). doi: 10.55184/ijpas.v73i1.23.
Guañabens N and Parés A. Osteoporosis in Chronic Liver Disease. Liver International. 2018 May; 38(5): 776-85. doi: 10.1111/liv.13730.
Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S et al. Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development. International Journal of Molecular Sciences. 2019 May; 20(10): 2555.doi: 10.3390/ijms20102555.
De A, Bhagat N, Mehta M, Singh P, Rathi S, Verma N et al. Central Obesity Is an Independent Determinant of Advanced Fibrosis in Lean Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology. 2025 Jan; 15(1): 102400. doi: 10.1016/j.jceh.2024.102400.
Al Knawy B. Health Care-Associated Transmission of Hepatitis B and C Viruses, An Issue of Clinics in Liver Disease. Elsevier Health Sciences. 2010 Feb.
Moin F, Qasim R, Ashraf M, Ali KQ. Prevalence of Osteoporosis in Patients with Chronic Liver Disease (CLD) in A Hospital; A Cross-Sectional Study. Journal of Pharmaceutical Negative Results. 2022 Oct; 13.
Nazir H, Chachar AZ, Khan MJ. Frequency of Osteoporosis in Patients of Chronic Liver Disease. Age. 2019; 30(40): 16.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
